A Study of ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB Subjects
Clinical trial NCT05561530 · TERMINATED
Trial details
- NCT number
- NCT05561530
- Sponsor
- Aligos Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-07
- Primary completion
- 2023-06-15
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.